Zimmer Biomet Holdings (ZBH)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$1.13 (-1.04%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Zimmer Biomet Holdings (ZBH)
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Key Insights

Critical company metrics and information
  • Share Price

    $108.03
  • Market Cap

    $21.51 Billion
  • Total Outstanding Shares

    199.07 Million Shares
  • Total Employees

    18,000
  • Dividend

    $0.24 Per Share Quarterly
  • IPO Date

    August 7, 2001
  • SIC Description

    Orthopedic, Prosthetic & Surgical Appliances & Supplies
  • Homepage

    https://www.zimmerbiomet.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow, Continuing$268.50 Million
Net Cash Flow$268.50 Million
Net Cash Flow From Investing Activities$-817.70 Million
Net Cash Flow From Financing Activities, Continuing$-495.30 Million
Net Cash Flow From Investing Activities, Continuing$-817.70 Million
Net Cash Flow From Operating Activities$1.58 Billion
Net Cash Flow From Operating Activities, Continuing$1.58 Billion
Net Cash Flow From Financing Activities$-495.30 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Operating Expenses$4.20 Billion
Net Income/Loss$1.08 Billion
Interest Income/Expense Operating, Net$-206.40 Million
Gross Profit$5.45 Billion
Income Tax Expense/Benefit$-52.70 Million
Costs And Expenses$6.34 Billion
Benefits Costs and Expenses$6.56 Billion
Net Income/Loss Available To Common Stockholders, Basic$1.08 Billion
Diluted Average Shares$204.80 Million
Operating Income/Loss$1.25 Billion
Income/Loss From Continuing Operations After Tax$1.08 Billion
Net Income/Loss Attributable To Parent$1.08 Billion
Cost Of Revenue$2.14 Billion
Interest Income/Expense After Provision For Losses$-206.40 Million
Income/Loss From Continuing Operations Before Tax$1.03 Billion
Provision For Loan, Lease, And Other Losses$0.00
Basic Average Shares$204.10 Million
Revenues$7.60 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Other Operating Expenses$344.40 Million
Basic Earnings Per Share$5.27
Diluted Earnings Per Share$5.24
Selling, General, and Administrative Expenses$2.91 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Net Income/Loss Attributable To Noncontrolling Interest$1.30 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Assets$21.72 Billion
Other Current Assets$2.50 Billion
Other Current Liabilities$3.25 Billion
Noncurrent Liabilities$5.77 Billion
Noncurrent Assets$16.86 Billion
Intangible Assets$4.67 Billion
Equity Attributable To Parent$12.37 Billion
Equity$12.38 Billion
Current Liabilities$3.57 Billion
Liabilities And Equity$21.72 Billion
Fixed Assets$2.11 Billion
Equity Attributable To Noncontrolling Interest$8.50 Million
Inventory$2.37 Billion
Other Non-current Assets$10.08 Billion
Current Assets$4.86 Billion
Liabilities$9.34 Billion
Accounts Payable$322.40 Million

Historical Dividends

Current dividend: $0.24 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Aug 29, 2024Oct 31, 2024Sep 30, 2024$0.24Quarterly
May 13, 2024Jul 31, 2024Jun 26, 2024$0.24Quarterly
Feb 21, 2024Apr 30, 2024Mar 29, 2024$0.24Quarterly
Dec 14, 2023Jan 31, 2024Dec 27, 2023$0.24Quarterly
Aug 25, 2023Oct 31, 2023Sep 29, 2023$0.24Quarterly
May 15, 2023Jul 31, 2023Jun 26, 2023$0.24Quarterly
Mar 8, 2023Apr 28, 2023Mar 29, 2023$0.24Quarterly
Dec 15, 2022Jan 31, 2023Dec 27, 2022$0.24Quarterly
Aug 26, 2022Oct 31, 2022Sep 30, 2022$0.24Quarterly
May 17, 2022Jul 29, 2022Jun 27, 2022$0.24Quarterly
Feb 22, 2022Apr 29, 2022Mar 29, 2022$0.24Quarterly
Nov 16, 2021Jan 31, 2022Dec 28, 2021$0.24Quarterly
Sep 3, 2021Oct 29, 2021Sep 30, 2021$0.24Quarterly
Jun 10, 2021Jul 30, 2021Jun 28, 2021$0.24Quarterly
Mar 11, 2021Apr 30, 2021Mar 29, 2021$0.24Quarterly
Dec 16, 2020Jan 29, 2021Dec 28, 2020$0.24Quarterly
Sep 10, 2020Oct 30, 2020Sep 30, 2020$0.24Quarterly
Jun 11, 2020Jul 31, 2020Jun 29, 2020$0.24Quarterly
Mar 10, 2020Apr 30, 2020Mar 27, 2020$0.24Quarterly
Dec 16, 2019Jan 31, 2020Dec 27, 2019$0.24Quarterly
Sep 3, 2019Oct 31, 2019Sep 30, 2019$0.24Quarterly
Jun 11, 2019Jul 31, 2019Jun 28, 2019$0.24Quarterly
Mar 7, 2019Apr 30, 2019Mar 29, 2019$0.24Quarterly
Dec 12, 2018Jan 31, 2019Dec 28, 2018$0.24Quarterly
Sep 13, 2018Oct 31, 2018Sep 28, 2018$0.24Quarterly
Jun 14, 2018Jul 31, 2018Jun 29, 2018$0.24Quarterly
Mar 12, 2018Apr 30, 2018Mar 29, 2018$0.24Quarterly
Dec 18, 2017Jan 29, 2018Dec 29, 2017$0.24Quarterly
Aug 7, 2017Oct 27, 2017Sep 22, 2017$0.24Quarterly
May 30, 2017Jul 28, 2017Jun 23, 2017$0.24Quarterly
Mar 1, 2017Apr 28, 2017Mar 31, 2017$0.24Quarterly
Dec 19, 2016Jan 27, 2017Dec 30, 2016$0.24Quarterly
Aug 23, 2016Oct 28, 2016Sep 23, 2016$0.24Quarterly
Feb 24, 2016Apr 29, 2016Mar 31, 2016$0.24Quarterly
Dec 14, 2015Jan 29, 2016Dec 31, 2015$0.22Quarterly
Aug 24, 2015Oct 30, 2015Sep 30, 2015$0.22Quarterly
May 5, 2015Jul 14, 2015May 15, 2015$0.22Quarterly
Feb 20, 2015Apr 24, 2015Mar 6, 2015$0.22Quarterly
Dec 12, 2014Jan 30, 2015Dec 29, 2014$0.22Quarterly
Aug 26, 2014Oct 31, 2014Sep 26, 2014$0.22Quarterly
May 6, 2014Jul 25, 2014Jun 27, 2014$0.22Quarterly
Feb 28, 2014Apr 25, 2014Mar 28, 2014$0.22Quarterly
Dec 13, 2013Jan 31, 2014Dec 27, 2013$0.2Quarterly
Jul 15, 2013Oct 25, 2013Sep 27, 2013$0.2Quarterly
May 7, 2013Jul 26, 2013Jun 28, 2013$0.2Quarterly
Feb 22, 2013Apr 26, 2013Mar 28, 2013$0.2Quarterly
Dec 11, 2012Jan 25, 2013Dec 27, 2012$0.18Quarterly

Related Companies

View additional S&P 500 companies similar to Zimmer Biomet Holdings (ZBH)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.